Subtype
Breast Intraductal Proliferative Lesion
CI-CAN-00000605DINExplore in graph →
Non-malignant2 active trials
- NCIt
- C27942
Loading cancer entity…
Subtype
CI-CAN-00000605DINExplore in graph →
Clinical trials
16 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06184750 | Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial | recruiting | Phase 2 | 200 | National Cancer Institute (NCI)NIH | 1 | Jul 27, 2026 | clinicaltrials |
Data updated 22 days agoSource updated Jul 27, 2026source: clinicaltrials